← FDA ENFORCEMENT
D-0293-2026Class II

Graviti Pharmaceuticals Private Limited

Recalling firm
Graviti Pharmaceuticals Private Limited
Product type
Drug
Status
Ongoing
Report date
2026-01-28
Distribution
U.S. Nationwide
Product quantity
4212 bottles
Initiated by
Voluntary: Firm initiated
Reason for recall

Presence of Foreign Substance

Product description

Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., East Brunswick, NJ 08816, Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, India, NDC 64980-563-10.

Code / lot info

Lot# FUB125042G; Exp. 05/13/2027

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.